cancer drug development, announced today that Hans Rosén is the new Managing Director at
the London office, and Dr. Jack Welch has joined the global clinical team leading medical
monitoring in Europe, both strengthening the company's European operations.
Theradex Oncology has designed and managed more than 250 early and late-phase oncology
trials over the past 3 decades. As a full service clinical CRO, the Theradex team has deep
experience assisting its clients in developing successful strategies for new cancer treatments.